Cryocell International Stock Today
| CCEL Stock | USD 8.90 0.10 1.11% |
Performance15 of 100
| Odds Of DistressLess than 10
|
CryoCell International is selling for 8.90 as of the 12th of May 2024. This is a -1.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 8.5. CryoCell International has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for CryoCell International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of May 2022 and ending today, the 12th of May 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of January 1997 | Category Healthcare | Classification Health Care |
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. The company has 8.1 M outstanding shares of which 9.45 K shares are currently shorted by private and institutional investors with about 1.78 trading days to cover. More on CryoCell International
Moving together with CryoCell Stock
| 0.71 | ELYM | Eliem Therapeutics Earnings Call Tomorrow | PairCorr |
Moving against CryoCell Stock
| 0.85 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.84 | EVOK | Evoke Pharma | PairCorr |
| 0.83 | SSY | SunLink Health Systems Earnings Call This Week | PairCorr |
| 0.79 | GILD | Gilead Sciences | PairCorr |
| 0.76 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.71 | CVS | CVS Health Corp | PairCorr |
| 0.67 | RDY | Dr Reddys Laboratories | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CryoCell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CryoCell International's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CryoCell International or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Co-CEO and Director | Mark Portnoy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering CryoCell International report their recommendations after researching CryoCell International's financial statements, talking to executives and customers, or listening in on CryoCell International's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering CryoCell International. The CryoCell consensus assessment is calculated by taking the average forecast from all of the analysts covering CryoCell International. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of CryoCell International's profitability, liquidity, and operating efficiency, CryoCell International may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of CryoCell International is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CryoCell International's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CryoCell International's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CryoCell International's financial leverage. It provides some insight into what part of CryoCell International's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CryoCell International (CCEL) is traded on NYSE MKT Exchange in USA. It is located in 700 Brooker Creek Boulevard, Oldsmar, FL, United States, 34677 and employs 82 people. CryoCell International is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CryoCell International's market, we take the total number of its shares issued and multiply it by CryoCell International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CryoCell International conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 8.1 M outstanding shares of which 9.45 K shares are currently shorted by private and institutional investors with about 1.78 trading days to cover.
CryoCell International currently holds about 2.96 M in cash with 8.92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Check CryoCell International Probability Of Bankruptcy
Ownership AllocationCryoCell International retains a total of 8.1 Million outstanding shares. CryoCell International retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check CryoCell Ownership Details
CryoCell Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of CryoCell International jumping above the current price in 90 days from now is nearly 4.35%. The CryoCell International probability density function shows the probability of CryoCell International stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days CryoCell International has a beta of 0.537 suggesting as returns on the market go up, CryoCell International average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CryoCell International will be expected to be much smaller as well. Additionally, cryoCell International has an alpha of 0.7507, implying that it can generate a 0.75 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of CryoCell International to move above the current price in 90 days from now is nearly 4.35 (This CryoCell International probability density function shows the probability of CryoCell Stock to fall within a particular range of prices over 90 days) .
CryoCell Stock Institutional Holders
Institutional Holdings refers to the ownership stake in CryoCell International that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CryoCell International's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CryoCell International's value.| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 600 | |
| Royal Bank Of Canada | 2023-12-31 | 103 | |
| Wells Fargo & Co | 2023-12-31 | 29.0 | |
| Jpmorgan Chase & Co | 2023-12-31 | 9.0 | |
| Bank Of America Corp | 2023-12-31 | 2.0 | |
| Hamilton Lane Advisors Llc | 2023-12-31 | 409.7 K | |
| Sfi Advisors, Llc | 2023-12-31 | 165.3 K | |
| Massmutual Trust Co Fsb/adv | 2023-12-31 | 114.2 K | |
| Vanguard Group Inc | 2023-12-31 | 91.1 K | |
| Northern Trust Corp | 2023-12-31 | 26.3 K | |
| Geode Capital Management, Llc | 2023-12-31 | 21 K |
CryoCell International Historical Income Statement
CryoCell International Income Statement is one of the three primary financial statements used for reporting CryoCell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CryoCell International revenue and expense. CryoCell International Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, CryoCell International's Non Recurring is quite stable compared to the past year. View More FundamentalsCryoCell Stock Against Markets
Picking the right benchmark for CryoCell International stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CryoCell International stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CryoCell International is critical whether you are bullish or bearish towards CryoCell International at a given time. Please also check how CryoCell International's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in CryoCell International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
CryoCell International Corporate Executives
Elected by the shareholders, the CryoCell International's board of directors comprises two types of representatives: CryoCell International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoCell. The board's role is to monitor CryoCell International's management team and ensure that shareholders' interests are well served. CryoCell International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoCell International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jill Taymans | CFO and VP of Fin. | Profile |
How to buy CryoCell Stock?
Before investing in CryoCell International, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in CryoCell International. To buy CryoCell International stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of CryoCell International. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase CryoCell International stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located CryoCell International stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased CryoCell International stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as CryoCell International, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy CryoCell Stock please use our How to Invest in CryoCell International guide.
Already Invested in CryoCell International?
The danger of trading CryoCell International is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CryoCell International is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CryoCell International. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CryoCell International is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.Note that the CryoCell International information on this page should be used as a complementary analysis to other CryoCell International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for CryoCell Stock analysis
When running CryoCell International's price analysis, check to measure CryoCell International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoCell International is operating at the current time. Most of CryoCell International's value examination focuses on studying past and present price action to predict the probability of CryoCell International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoCell International's price. Additionally, you may evaluate how the addition of CryoCell International to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is CryoCell International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Earnings Share (1.16) | Revenue Per Share 3.783 | Quarterly Revenue Growth 0.004 | Return On Assets (0.01) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.